110 related articles for article (PubMed ID: 38749791)
1. Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis.
Oh SY; Kim CW; Kim S; Kim MH; Kim YI; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS
Clin Colorectal Cancer; 2024 Jun; 23(2):135-146.e3. PubMed ID: 38749791
[TBL] [Abstract][Full Text] [Related]
2. The prognostic and predictive significance of perineural invasion in stage I to III colon cancer: a propensity score matching-based analysis.
Chu CH; Lai IL; Jong BK; Chiang SF; Tsai WS; Hsieh PS; Yeh CY; You JF
World J Surg Oncol; 2024 May; 22(1):129. PubMed ID: 38734718
[TBL] [Abstract][Full Text] [Related]
3. Outcome of colon cancer initially presenting as colon perforation and obstruction.
Chen TM; Huang YT; Wang GC
World J Surg Oncol; 2017 Aug; 15(1):164. PubMed ID: 28841901
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy and prognostic factors in stage II colon cancer--Izmir Oncology Group Study.
Kucukzeybek Y; Dirican A; Demir L; Yildirim S; Akyol M; Yildiz Y; Bayoglu IV; Alacacioglu A; Varol U; Salman T; Yildiz I; Can H; Tarhan MO
Asian Pac J Cancer Prev; 2015; 16(6):2413-8. PubMed ID: 25824774
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
7. Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
Sadahiro S; Sakamoto K; Tsuchiya T; Takahashi T; Ohge H; Sato T; Kondo K; Ogata Y; Baba H; Itabashi M; Ikeda M; Hamada M; Maeda K; Masuko H; Takahashi K; Sakamoto J; Kusano M; Hyodo I; Taguri M; Morita S
BMC Cancer; 2022 Feb; 22(1):170. PubMed ID: 35168560
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
[TBL] [Abstract][Full Text] [Related]
9. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
[TBL] [Abstract][Full Text] [Related]
11. Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial.
Dahdaleh FS; Sherman SK; Poli EC; Vigneswaran J; Polite BN; Sharma MR; Catenacci DV; Maron SB; Turaga KK
Surgery; 2018 Dec; 164(6):1223-1229. PubMed ID: 30297240
[TBL] [Abstract][Full Text] [Related]
12. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Surgery; 2000 Apr; 127(4):370-6. PubMed ID: 10776426
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
[TBL] [Abstract][Full Text] [Related]
14. Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study.
Artac M; Turhal NS; Kocer M; Karabulut B; Bozcuk H; Yalcin S; Karaagac M; Gündüz S; Isik N; Uygun K
Tumori; 2014; 100(2):143-8. PubMed ID: 24852857
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implications of Endoscopic Obstruction in Patients with Pathological Stage II Colon Cancers: a Single-Center Retrospective Cohort Study.
Mo TW; Zhang ZJ; Shi YQ; Xiang HD; Chen YL; Chen ZX; Hu JC; He XW
J Gastrointest Surg; 2023 Jan; 27(1):141-151. PubMed ID: 36352061
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer.
Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Sci Rep; 2019 Aug; 9(1):11846. PubMed ID: 31413354
[TBL] [Abstract][Full Text] [Related]
17. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Decompressing Stoma vs Stent as a Bridge to Surgery for Left-Sided Obstructive Colon Cancer.
Veld JV; Amelung FJ; Borstlap WAA; van Halsema EE; Consten ECJ; Siersema PD; Ter Borg F; van der Zaag ES; de Wilt JHW; Fockens P; Bemelman WA; van Hooft JE; Tanis PJ;
JAMA Surg; 2020 Mar; 155(3):206-215. PubMed ID: 31913422
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of perineural invasion in stage IIA colon cancer.
Yun JA; Kim HC; Kim SH; Cho YB; Yun SH; Lee WY; Chun HK
ANZ J Surg; 2016 Dec; 86(12):1007-1013. PubMed ID: 25113398
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy].
Zhou ZG; Pan ZZ; Wan DS; Li LR; Wu XJ; Ding PR; Lin JZ; Peng ZH
Ai Zheng; 2009 Sep; 28(9):908-12. PubMed ID: 19728905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
